openPR Logo
Press release

Pompe Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Sanofi, Amicus Therapeutics

10-16-2023 12:32 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Pompe Disease  Market Outlook

Pompe Disease Market Outlook

DelveInsight's "Pompe Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Download the Sample Report to learn more

@https://www.delveinsight.com/sample-request/pompe-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Pompe Disease Overview

Pompe disease is a genetic condition in which a complex sugar called glycogen builds up in the lysosomes of your body's cells. The disease occurs when you lack a specific digestive enzyme called acid alpha-glucosidase (GAA). The condition causes severe muscle weakness and wasting.
It is caused by mutations in a gene that makes an enzyme called acid alpha-glucosidase (GAA), which the body uses to break down glycogen, a stored form of sugar used for energy. The enzyme performs its function in intracellular compartments called lysosomes, which function as cellular clearinghouses.

Click here to learn more about the Pompe Disease Market Landscape @https://www.delveinsight.com/sample-request/pompe-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlights from Pompe Disease Market Report
Key Pharmaceutical companies working in the Pompe Disease market include Sanofi, Amicus Therapeutics, Actus Therapeutics, Valerion Therapeutics, and many others
Key Therapies involved in the Pompe Disease market include Filgrastim, Rapamycin, VAL-1221, and many others
Market size of the Pompe Disease market is expected to be USD XX million by 2032.
The CAGR of the Pompe Disease market is expected to be at XX%.
Pompe Disease is a rare complication of multiple myeloma. It's caused by the buildup of abnormal proteins in the blood that clump together in temperatures below normal body temperature.
Most people with myeloma who develop Pompe Disease experience skin symptoms. They often have severe symptoms such as necrotic ulcers or gangrene. These symptoms can be life-threatening and require immediate medical attention.
Learn more about the treatment market for Pompe Disease market @https://www.delveinsight.com/report-store/pompe-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Pompe Disease market Epidemiology Segmented by:
Pompe Disease Incident Cases
Pompe Disease Prevalent Cases
Pompe Disease Treatment Cases
Pompe Disease Diagnosed Cases
Pompe Disease Drug Profile and Companies Covered
Sanofi: Filgrastim, Rapamycin, VAL-1221,
Amicus Therapeutics: Rapamycin
Actus Therapeutics: VAL-1221
And many others
Learn more about the Key Companies and Emerging Therapies in the Pompe Disease Market @https://www.delveinsight.com/report-store/pompe-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Pompe Disease Market Introduction
Executive Summary of Pompe Disease Market
Disease Background and Overview
Pompe Disease Market Epidemiology and Patient Population
Pompe Disease Market Emerging Therapies
Pompe Disease Market Outlook
Pompe Disease Market Access and Reimbursement of Therapies
Pompe Disease Market Drivers
Pompe Disease Market Barriers
Appendix
Pompe Disease Market Report Methodology
DelveInsight Capabilities
Disclaimer

Learn about the detailed offerings of the Pompe Disease Market Outlook report @https://www.delveinsight.com/report-store/pompe-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Inflammatory Breast Cancer market Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pompe Disease Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- Sanofi, Amicus Therapeutics here

News-ID: 3250973 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Pompe

Pompe Disease Market Trends That Will Shape the Next Decade: Insights from Innov …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Pompe Disease Market Size By 2025? The market scale for Pompe disease has seen a consistent growth over the past few years. Its size is expected to increase from the current $1.74 billion in 2024 to about $1.8 billion in 2025, exhibiting a compound annual
Leading Element Driving Change in the Pompe Disease Market in 2025: Rising Preva …
How Are the key drivers contributing to the expansion of the pompe disease market? The surge in the occurrence of Pompe disease, which is also known as glycogen storage disease type II or acid maltase deficiency, is anticipated to contribute significantly to the expansion of the Pompe disease market. This rare genetic condition is marked by an accumulation of glycogen, or a complex sugar molecule, in muscles and different body tissues.
Pompe Disease Therapeutics and Treatment Market Report 2024
"The Business Research Company recently released a comprehensive report on the Global Pompe Disease Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Pompe Disease Treatment Drugs, Pipeline Insight Report 2024
DelveInsight's, "Pompe Disease Pipeline Insight 2024" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Pompe
Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market - Restoring Bal …
Newark, New Castle, USA: The "Gaucher & Pompe Diseases Enzyme Replacement Therapy (ERT) Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gaucher & Pompe Diseases Enzyme Replacement
Pompe Disease Therapeutic Market - Increasing prevalence of pompe disease in man …
Pompe Disease Therapeutic Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Pompe Disease Therapeutic Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive